Your browser doesn't support javascript.
loading
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial.
Karoui, Mehdi; Gallois, Claire; Piessen, Guillaume; Legoux, Jean-Louis; Barbier, Emilie; De Chaisemartin, Cecile; Lecaille, Cedric; Bouche, Olivier; Ammarguellat, Hanifa; Brunetti, Francesco; Prudhomme, Michel; Regimbeau, Jean-Marc; Glehen, Olivier; Lievre, Astrid; Portier, Guillaume; Hartwig, Johannes; Goujon, Gael; Romain, Benoit; Lepage, Come; Taieb, Julien.
Affiliation
  • Karoui M; Department of Digestive and Oncological Surgery, AP-HP; Hôpital Européen Georges Pompidou, Paris University, Paris, France.
  • Gallois C; Department of Hepato-gastroenterology and Digestive Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris University, Paris, France.
  • Piessen G; Department of Digestive and Oncological Surgery, Lille University Hospital, Lille, France.
  • Legoux JL; Department of Hepato-gastroenterology and Digestive Oncology, CHR La Source, Orléans, France.
  • Barbier E; Biostatistics, FFCD, EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
  • De Chaisemartin C; Department of Digestive Surgery, Institut Paoli Calmettes, Marseille, France.
  • Lecaille C; Department of Oncology, Polyclinique Bordeaux Nord, Bordeaux, France.
  • Bouche O; Department of Digestive Oncology, CHU Robert Debré, Reims, France.
  • Ammarguellat H; Department of Medical Oncology, CH Beauvais, Beauvais, France.
  • Brunetti F; Department of Digestive Surgery, AP-HP, CHU Henri Mondor, Créteil, France.
  • Prudhomme M; Department of Digestive Surgery, CHU Carémeau, Nîmes, France.
  • Regimbeau JM; Department of Digestive Surgery, Amiens University Hospital, France.
  • Glehen O; Department of Digestive Surgery, CHU Lyon Sud, Lyon, France.
  • Lievre A; Department of Gastroenterology, CHU Rennes, Rennes 1 University, Rennes, France.
  • Portier G; Department of Digestive Surgery, CHU Rangueil, Toulouse, France.
  • Hartwig J; Department of Gastroenterology, Infirmerie Protestante, Caluire-et-Cuire, France.
  • Goujon G; Department of Gastroenterology, Paris VII, AP-HP, BCHU Bichat, Paris, France.
  • Romain B; Department of Digestive Surgery, CHU Hautepierre, Strasbourg, France.
  • Lepage C; Hepato-gastroenterology and Digestive Oncology Department, FFCD, EPICAD INSERM LNC-UMR 1231, CHU Dijon, University of Burgundy and Franche Comté, Dijon, France.
  • Taieb J; Department of Hepato-gastroenterology and Digestive Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris University, Paris, France.
Colorectal Dis ; 23(6): 1357-1369, 2021 06.
Article in En | MEDLINE | ID: mdl-33580623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Colorectal Dis Year: 2021 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Colorectal Dis Year: 2021 Type: Article Affiliation country: France